Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.07
Delayed Data
As of 3:59pm ET
 +0.15 / +1.89%
Today’s Change
5.49
Today|||52-Week Range
9.54
+2.54%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.92
Today’s open7.90
Day’s range7.80 - 8.11
Volume268,227
Average volume (3 months)477,440
Market cap$616.9M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+121.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.87

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.02-0.10%
NTRANatera Inc+0.19+1.97%
GHDXGenomic Health Inc-0.53-2.00%
RDNTRadNet Inc+0.03+0.45%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs